Product Code: 25EL-581-2035
Please note: This is a Single Viewer eCast registration for one participant for this eCast for both the live and on-demand version of this eCast. If you are interested in presenting this program to a group, please see the “eCast Registration Form– Group Viewing” form on the eCast program page.
Access instructions for the live eCast will be provided via email approximately 2-3 business days prior to the live program date. Access instructions for the on-demand version of this program will be provided via email approximately 3-10 business days after the live program has occurred and the on-demand version is available.
Program Description: This program will provide an in-depth exploration of coding and reimbursement for cellular therapies, with a focus on CAR-T, stem cell, and tumor-derived therapies like AMTAGVI. Participants will learn how to navigate the latest CMS rule changes and address reimbursement challenges through case studies from healthcare facilities. The program will equip attendees with practical tools like prior authorization checklists, appeal templates, and medical necessity resources to improve reimbursement processes. Additionally, the program will highlight AABB's ongoing advocacy efforts and discuss potential regulatory changes that could impact future reimbursement strategies.
